Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden

British Journal of Haematology

Volumn 164, Issue 5, 2014, Pages 675-683

  Lorenzo Bermejo, Justo ^a,b   Pukkala, Eero ^c,d   Johannesen, Tom B ^e   Sundquist, Jan ^f,g   Hemminki, Kari ^b,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c FINNISH CANCER REGISTRY   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f LUND UNIVERSITY   (Sweden)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Absolute risks; Non Hodgkin lymphoma; Population based risk estimates; Relative risks; Second neoplasms

Indexed keywords

ABSOLUTE RISKS; NON-HODGKIN LYMPHOMA; POPULATION-BASED RISK ESTIMATES; RELATIVE RISKS; SECOND NEOPLASMS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NORWAY; REGISTRIES; RISK ASSESSMENT; SWEDEN; TIME FACTORS;

EID: 84894024681     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12684     Document Type: Article

References (25)

1. Brandt, L., Kimby, E., Nygren, P. & Glimelius, B. (2001) A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma. Acta Oncologica, 40, 213-223.
2. Brennan, P., Scelo, G., Hemminki, K., Mellemkjaer, L., Tracey, E., Andersen, A., Brewster, D.H., Pukkala, E., McBride, M.L., Kliewer, E.V., Tonita, J.M., Seow, A., Pompe-Kirn, V., Martos, C., Jonasson, J.G., Colin, D. & Boffetta, P. (2005) Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. British Journal of Cancer, 93, 159-166.
3. Cogliano, V.J., Baan, R., Straif, K., Grosse, Y., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L. & Wild, C.P. (2011) Preventable exposures associated with human cancers. Journal of the National Cancer Institute, 103, 1827-1839.
4. Engholm, G., Ferlay, J., Christensen, N., Johannesen, T.B., Klint, Å., Køtlum, J.E., Milter, M.C., Ólafsdóttir, E., Pukkala, E. & Storm, H.H. (2012) NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 5.3 (25.04.2013). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu, accessed on 31/10/2013.
5. Frodin, J.E., Ericsson, J. & Barlow, L. (1997) Multiple primary malignant tumors in a national cancer registry-reliability of reporting. Acta Oncologica, 36, 465-469.
6. Hasselblom, S., Stenson, M., Werlenius, O., Sender, M., Lewerin, C., Hansson, U., Nilsson-Ehle, H. & Andersson, P.O. (2012) Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era. Leukaemia & Lymphoma, 53, 394-399.
7. Hemminki, K., Lenner, P., Sundquist, J. & Lorenzo Bermejo, J. (2008) Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. Journal of Clinical Oncology, 26, 1850-1857.
8. Hijiya, N., Hudson, M.M., Lensing, S., Zacher, M., Onciu, M., Behm, F.G., Razzouk, B.I., Ribeiro, R.C., Rubnitz, J.E., Sandlund, J.T., Rivera, G.K., Evans, W.E., Relling, M.V. & Pui, C.H. (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA, 297, 1207-1215.
9. Hodgson, D.C., Gilbert, E.S., Dores, G.M., Schonfeld, S.J., Lynch, C.F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., Kaijser, M., Joensuu, H., Fossa, S.D. & Travis, L.B. (2007) Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. Journal of Clinical Oncology, 25, 1489-1497.
10. Jaffe, E.S. (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology/the Education Program of the American Society of Hematology, 2009, 523-531.
11. Ji, J., Forsti, A., Sundquist, J., Lenner, P. & Hemminki, K. (2009) Survival in non-Hodgkin's lymphoma by histology and family history. Journal of Cancer Research and Clinical Oncology, 135, 1711-1716.
12. Kimby, E., Brandt, L., Nygren, P. & Glimelius, B. (2001) A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma. Acta Oncologica, 40, 198-212.
13. Larsen, I.K., Smastuen, M., Johannesen, T.B., Langmark, F., Parkin, D.M., Bray, F. & Moller, B. (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. European Journal of Cancer, 45, 1218-1231.
14. Maule, M., Scelo, G., Pastore, G., Brennan, P., Hemminki, K., Tracey, E., Sankila, R., Weiderpass, E., Olsen, J.H., McBride, M.L., Brewster, D.H., Pompe-Kirn, V., Kliewer, E.V., Chia, K.S., Tonita, J.M., Martos, C., Jonasson, J.G., Merletti, F. & Boffetta, P. (2007) Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. Journal of the National Cancer Institute, 99, 790-800.
15. Meadows, A.T., Friedman, D.L., Neglia, J.P., Mertens, A.C., Donaldson, S.S., Stovall, M., Hammond, S., Yasui, Y. & Inskip, P.D. (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. Journal of Clinical Oncology, 27, 2356-2362.
16. Metayer, C., Lynch, C.F., Clarke, E.A., Glimelius, B., Storm, H., Pukkala, E., Joensuu, T., van Leeuwen, F.E., van't Veer, M.B., Curtis, R.E., Holowaty, E.J., Andersson, M., Wiklund, T., Gospodarowicz, M. & Travis, L.B. (2000) Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. Journal of Clinical Oncology, 18, 2435-2443.
17. Mudie, N.Y., Swerdlow, A.J., Higgins, C.D., Smith, P., Qiao, Z., Hancock, B.W., Hoskin, P.J. & Linch, D.C. (2006) Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study. Journal of Clinical Oncology, 24, 1568-1574.
18. Preston, D.L., Pierce, D.A., Shimizu, Y., Cullings, H.M., Fujita, S., Funamoto, S. & Kodama, K. (2004) Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiation Research, 162, 377-389.
19. Storm, H.H., Klint, A., Tryggvadottir, L., Gislum, M., Engholm, G., Bray, F. & Hakulinen, T. (2010) Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncologica, 49, 694-712.
20. Swedish Centre for Epidemiology (2010) Cancer Incidence in Sweden 2009. The National Board of Health and Welfare, Swedish Ministry of Health, Stockholm, Sweden.
21. Swerdlow, A.J., Barber, J.A., Hudson, G.V., Cunningham, D., Gupta, R.K., Hancock, B.W., Horwich, A., Lister, T.A. & Linch, D.C. (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. Journal of Clinical Oncology, 18, 498-509.
22. Travis, L.B. (2006) The epidemiology of second primary cancers. Cancer Epidemiology, Biomarkers and Prevention, 15, 2020-2026.
23. Travis, L.B., Curtis, R.E., Glimelius, B., Holowaty, E., Van Leeuwen, F.E., Lynch, C.F., Adami, J., Gospodarowicz, M., Wacholder, S., Inskip, P., Tucker, M.A., Fraumeni, J.F. & Boice, J.D. (1993) Second cancers among long-term survivors of non-Hodgkin's lymphoma. Journal of the National Cancer Institute, 85, 1932-1937.
24. Tward, J.D., Wendland, M.M., Shrieve, D.C., Szabo, A. & Gaffney, D.K. (2006) The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer, 107, 108-115.
25. Welch, H.G. & Black, W.C. (2010) Overdiagnosis in cancer. Journal of the National Cancer Institute, 102, 605-613.